Remove 2020 Remove Conditions Remove Treatment
article thumbnail

The Changing Landscape of Medical Marijuana in Massachusetts: What Patients Should Know

Canna Care Docs

While patient enrollment peaked in 2020, current levels remain significantly higher than when recreational cannabis became legal in 2018. Verified Dispensary Licensing Data: As of February 2025, the Cannabis Control Commission (CCC) reports 87 expired or surrendered Medical Treatment Center (MTC) licenses.

article thumbnail

The Science Behind Marijuana’s Effects on OCD Symptoms

LifeCannMD

Fernando Fandio-Sende researches innovative approaches to OCD treatment that have emerged, with medical marijuana integrative wellness strategies increasingly recognized as a potential therapeutic avenue worth exploring. This gives us another way to think about treating the condition.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Microdosing Cannabis in Miami: What It Is and How It Might Help

LifeCannMD

Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients. times more likely to achieve their treatment goals with medical cannabis. This gives us baseline measurements that we can track over time. “What About Tolerance?”

article thumbnail

The Science Behind Charlotte’s Web: How CBD Oil Works for Seizure Disorders

LifeCannMD

Every medication, every treatment, every specialist they could find. CBD acts like anti-rust treatment for your brain. Florida recognizes epilepsy as a qualifying condition, so you don’t need to prove that everything else failed first. We’ll talk about your history, current treatments, and how cannabis might help.

CBD 52
article thumbnail

Colorado “Healing Centers” Could Lay Groundwork For Widespread Psychedelic Therapy

Veriheal

Voters in Oregon passed Measure 109 via the ballot box in 2020 , marking the first time any state allowed licensed providers to use psilocybin in a therapy setting for people 21 and over. These locations must securely store psilocybin when not in use, especially if they also offer traditional treatments during other hours.

Therapy 59
article thumbnail

MDMA Failed to Receive FDA Approval: What Happens Next?

Veriheal

Federal health regulators recently declined to approve the use of the psychedelic drug midomafetamine (3,4-methylenedioxymethamphetamine or MDMA) as a treatment for post-traumatic stress disorder (PTSD), disappointing many advocates who were hopeful for the next breakthrough in the psychedelic therapy movement.

article thumbnail

Louisiana: Governor Signs Bills Into Law Facilitating Expanded Cannabis Access for Patients

NORML

Late last week, the Governor signed House Bill 819, which expands the discretion of physicians so that they can recommend cannabis therapy for “any condition” that he or she “considers debilitating to an individual patient and is qualified through his [or her] medical education and training to treat.”

Access 320